or Try an Advanced Search...

    Technical Analysis for TLPH - Talphera, Inc.

    Grade Last Price % Change Price Change
    D 0.92 2.96% 0.03
    TLPH closed up 2.96 percent on Monday, July 1, 2024, on 42 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical TLPH trend table...
    Date Alert Name Type % Chg
    Crossed Above 200 DMA Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Fell Below 200 DMA Bearish 2.96%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.96%
    Wide Bands Range Expansion 2.96%
    Crossed Above 200 DMA Bullish 0.69%
    Wide Bands Range Expansion 0.69%
    200 DMA Resistance Bearish 4.13%
    Calm After Storm Range Contraction 4.13%
    Wide Bands Range Expansion 4.13%
    Older End-of-Day Signals for TLPH ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 7 hours ago
    Down 3% about 7 hours ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 7 hours ago
    Fell Below Previous Day's Low about 7 hours ago
    Down 2 % about 7 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TLPH Chart by TradingView
    Basic chart:

    Profile

    Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the FDA. Talphera is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe. This release is intended for investors only
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Pharmaceutical Medication Medical Equipment FDA Syringe Drug Paraphernalia Innovative Therapies Phenylephrine Investigational Device Exemption

    Is TLPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 20 Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    May 16 Talphera to Participate at A.G.P. Virtual Healthcare Conference
    May 14 Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript
    May 14 AcelRx Pharmaceuticals GAAP EPS of -$0.16 beats by $0.06
    May 14 Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
    May 13 AcelRx Pharmaceuticals Q1 2024 Earnings Preview
    May 2 Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024
    Mar 7 Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript
    Mar 6 AcelRx Pharmaceuticals GAAP EPS of -$0.25, revenue of $0.3M
    Mar 6 Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update
    See more TLPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.61
    52 Week Low 0.425
    Average Volume 65,410
    200-Day Moving Average 0.89
    50-Day Moving Average 1.00
    20-Day Moving Average 0.94
    10-Day Moving Average 0.88
    Average True Range 0.08
    RSI (14) 47.09
    ADX 18.23
    +DI 18.22
    -DI 25.97
    Chandelier Exit (Long, 3 ATRs) 0.87
    Chandelier Exit (Short, 3 ATRs) 1.01
    Upper Bollinger Bands 1.09
    Lower Bollinger Band 0.79
    Percent B (%b) 0.41
    BandWidth 31.43
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram -0.0005
    Fundamentals Value
    Market Cap 15.53 Million
    Num Shares 17 Million
    EPS
    Price-to-Sales 50.40
    Price-to-Book 0.80
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.01
    Resistance 3 (R3) 1.00 0.96 1.00
    Resistance 2 (R2) 0.96 0.94 0.97 0.99
    Resistance 1 (R1) 0.94 0.92 0.95 0.95 0.99
    Pivot Point 0.90 0.90 0.90 0.90 0.90
    Support 1 (S1) 0.87 0.87 0.89 0.88 0.85
    Support 2 (S2) 0.83 0.86 0.84 0.84
    Support 3 (S3) 0.81 0.83 0.84
    Support 4 (S4) 0.82